#USA #New York #class action lawsuit #Bronstein Gewirtz #Neogen Corporation

Neogen Corporation Investors Taking Legal Action

Neogen Corporation, publicly traded under the NASDAQ ticker NEOG, is currently facing legal scrutiny from its investors after a substantial loss in stock value. The class action lawsuit, spearheaded by Bronstein, Gewirtz & Grossman, LLC, has come as a relief for many investors who felt blindsided by the company's recent misrepresentation of its financial status and operational progress.

Class Action Details

The suit specifically seeks to defend the rights of investors who purchased or obtained Neogen securities between January 5, 2023, and June 3, 2025. During this time, the complaint asserts that key executives at Neogen were misleading in their communication. They allegedly portrayed the integration of operations as smooth and successful, despite experiencing a series of inefficiencies that they downplayed or failed to disclose.

The ramifications of these misleading statements became clear on June 4, 2025, when Neogen announced expected EBITDA margins in the high teens, significantly lower than the 22% margin from the previous quarter. This abrupt revelation sent shockwaves through the investor community and resulted in notable losses for many stakeholders.

The Law Firm’s Role

Bronstein, Gewirtz & Grossman is a nationally recognized law firm known for representing investors in securities fraud cases. They assert that this class action lawsuit offers an essential platform for aggrieved investors to recover their losses. Investors are encouraged to visit their website at bgandg.com/NEOG to find out more about how they can participate in this important legal battle.

For those regretting their investment decisions and interested in pursuing action, there’s a deadline to bear in mind: September 16, 2025. This is the last day for potential lead plaintiffs to apply through the court. However, participation in any financial recovery does not necessitate leading the lawsuit.

No Financial Risk Involved

It's also worth noting that Bronstein, Gewirtz & Grossman operates on a contingency fee basis. This means that investors who decide to join the class action will not have to worry about upfront costs. Legal fees will be deducted from any potential recovery, providing a low-risk option for investors aiming to reclaim their lost funds.

Why This Matters

This class action has garnered attention due to the magnitude of the alleged misconduct involved with Neogen’s operations. With hundreds of millions already recovered for investors in prior cases, Bronstein, Gewirtz & Grossman firmly believes they can achieve favorable outcomes for those affected by Neogen’s loss, maintaining their reputation as a reliable advocate for investor rights.

As updates continue to emerge, follow Bronstein, Gewirtz & Grossman on platforms such as LinkedIn and social media to stay informed on the progress and any significant developments regarding this case.

Conclusion

Investors affected by Neogen Corporation’s recent troubles now have a recourse through this class action lawsuit. It presents a formidable opportunity to seek justice for the financial losses incurred due to alleged securities fraud within the company. To quote legal experts, being informed is half the battle; the other half is taking action. Don’t let your voice go unheard—consider joining the collective effort towards accountability and recovery.